Literature DB >> 9076942

Transforming growth factor beta s and wound healing.

S O'Kane1, M W Ferguson.   

Abstract

The Transforming Growth Factor beta superfamily (TGF beta) is one of the most complex groups of cytokines with widespread effects on many aspects of growth and development. The TGF beta isoforms and other family members, e.g. Activins and BMPs, have diverse effects in similar physiological situations. TGF beta is involved in the wound healing process. The three mammalian isoforms (TGF beta 1, 2 and 3) and recently other family members, e.g. Activin, have been localised in healing wounds. Manipulation of the ratios of TGF beta superfamily members, particularly the ratio of TGF beta 1 relative to TGF beta 3, reduces scarring and fibrosis. Such manipulations include reducing the levels of TGF beta 1/TGF beta 2 using neutralising antibodies or preventing the activation of TGF beta s. In chronic or impaired wounds the exogenous addition of TGF beta superfamily members accelerates aspects of the healing process. This review summarises evidence for the role of TGF beta superfamily members in wound healing and how modulation of TGF beta levels can prevent scarring and fibrosis.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9076942     DOI: 10.1016/s1357-2725(96)00120-3

Source DB:  PubMed          Journal:  Int J Biochem Cell Biol        ISSN: 1357-2725            Impact factor:   5.085


  118 in total

1.  Transforming growth factor-beta initiates wound repair in rat liver through induction of the EIIIA-fibronectin splice isoform.

Authors:  J George; S S Wang; A M Sevcsik; M Sanicola; R L Cate; V E Koteliansky; D M Bissell
Journal:  Am J Pathol       Date:  2000-01       Impact factor: 4.307

Review 2.  Skin scarring.

Authors:  A Bayat; D A McGrouther; M W J Ferguson
Journal:  BMJ       Date:  2003-01-11

3.  Drug-loaded polymeric composite skin graft for infection-free wound healing: fabrication, characterization, cell proliferation, migration, and antimicrobial activity.

Authors:  Anupama Mittal; Neeraj Kumar
Journal:  Pharm Res       Date:  2012-06-28       Impact factor: 4.200

Review 4.  Role of transforming growth factor Beta in corneal function, biology and pathology.

Authors:  A Tandon; J C K Tovey; A Sharma; R Gupta; R R Mohan
Journal:  Curr Mol Med       Date:  2010-08       Impact factor: 2.222

Review 5.  The Use of Biologic Scaffolds in the Treatment of Chronic Nonhealing Wounds.

Authors:  Neill J Turner; Stephen F Badylak
Journal:  Adv Wound Care (New Rochelle)       Date:  2015-08-01       Impact factor: 4.730

6.  Peptide ligands that use a novel binding site to target both TGF-β receptors.

Authors:  Lingyin Li; Brendan P Orner; Tao Huang; Andrew P Hinck; Laura L Kiessling
Journal:  Mol Biosyst       Date:  2010-10-04

7.  Ageing, science and the cosmetics industry. The micro-inflammatory model serves as a basis for developing effective anti-ageing products for the skin.

Authors:  Paolo U Giacomoni
Journal:  EMBO Rep       Date:  2005-07       Impact factor: 8.807

8.  Reversal of abnormal collagen production in Crohn's disease intestinal biopsies treated with regenerating agents.

Authors:  C Alexakis; J P Caruelle; A Sezeur; J Cosnes; J P Gendre; H Mosnier; L Beaugerie; D Gallot; M Malafosse; D Barritault; P Kern
Journal:  Gut       Date:  2004-01       Impact factor: 23.059

9.  Fibromodulin Is Essential for Fetal-Type Scarless Cutaneous Wound Healing.

Authors:  Zhong Zheng; Xinli Zhang; Catherine Dang; Steven Beanes; Grace X Chang; Yao Chen; Chen-Shuang Li; Kevin S Lee; Kang Ting; Chia Soo
Journal:  Am J Pathol       Date:  2016-09-22       Impact factor: 4.307

10.  WOUND-HEALING PROPERTIES OF TRANSFORMING GROWTH FACTOR β (TGF-β) INDUCIBLE EARLY GENE 1 (TIEG1) KNOCKOUT MICE.

Authors:  Manabu Taguchi; Steven L Moran; Mark E Zobitz; Chunfeng Zhao; Malayannan Subramaniam; Thomas C Spelsberg; Peter C Amadio
Journal:  J Musculoskelet Res       Date:  2008-06-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.